Idexx Laboratories (IDXX) Total Debt (2009 - 2026)

Idexx Laboratories has reported Total Debt for 18 years, with the latest figure at $818.9 million in Q2 2026.

• On a quarterly basis, Total Debt fell 20.41% year-over-year to $818.9 million in Q2 2026; TTM through Jun 2026 was $818.9 million, a 20.41% decrease from a year earlier, with the FY2025 full-year figure at $772.8 million, up 10.44% from the prior year.
• Total Debt was $818.9 million for Q2 2026 at Idexx Laboratories, down from $829.9 million in the prior quarter.
• The five-year high for Total Debt was $1.4 billion in Q3 2022, with the low at $699.8 million in Q4 2024.
• Average Total Debt over 5 years is $938.4 million, with a median of $869.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Total Debt surged 63.4% in 2022, then tumbled 37.67% in 2023.
• Over 5 years, Total Debt stood at $944.4 million in 2022, then fell by 7.57% to $872.9 million in 2023, then dropped by 19.83% to $699.8 million in 2024, then rose by 10.44% to $772.8 million in 2025, then rose by 5.96% to $818.9 million in 2026.
• The last three Total Debt figures came in at $818.9 million (Q2 2026), $829.9 million (Q1 2026), and $772.8 million (Q4 2025), per Business Quant data.